Haleon, the consumer healthcare company behind brands including Sensodyne, Panadol and Tums, has appointed a new chair.

With Kimberly-Clark shelling out nearly $49 billion to buy Kenvue, which was originally J&J’s over-the-counter medicine ...

Nov 3 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio ...

(Reuters) -India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio. The Indian unit of British ...

GLAXOSMITHKLINE, best known for its widely used asthma inhaler Advair, is making changes worldwide that are meant to produce about $US1.6 billion ($A1.73 billion) in ...

The outgoing pharma chief exec (pictured) said it was 'absolutely critical' that the government 'incentivise' investment in the sector.

Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke Miels, Deborah Waterhouse, and Julie Brown, with Tony Wood, David ...

GSK GSK2.85%increase; green up pointing triangle raised its sales and earnings forecasts for the year after its specialty medicines business helped lift sales in the third quarter, the last reporting ...

Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. The GSK executives are ...

GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s last report as chief executive officer. The British drugmaker expects earnings ...

GSK’s antibody-drug conjugate strategy may be making more headlines recently, but the British pharma hasn’t forgotten about oligonucleotides. The drugmaker is paying $85 million upfront to Empirico ...

GSK will pay privately held Empirico $85 million for the rights to an experimental therapy that may treat a range of patients with chronic obstructive pulmonary disease, or COPD. Empirico is currently ...